IDF21-0470 Neither plasma glucose at admission nor in-hospital hyperglycaemia predict poor clinical outcomes in COVID-19 patients
Poonam Sharma(Indian Institute of Science Education and Research Mohali), Manan Bhasin(Emory University), Namrata Sachdeva(Post Graduate Institute of Medical Education and Research), Minu Singh(Post Graduate Institute of Medical Education and Research), Akhil Kumar(Post Graduate Institute of Medical Education and Research), Sant Ram(Post Graduate Institute of Medical Education and Research), Ravinder Pal(Post Graduate Institute of Medical Education and Research), K. S(Post Graduate Institute of Medical Education and Research), Viney Dhiman(Post Graduate Institute of Medical Education and Research), Ashish Bhalla(Office of Infectious Diseases), S K Bhadada(Post Graduate Institute of Medical Education and Research), G. D. Puri(Post Graduate Institute of Medical Education and Research)
Cited by 0
Related Papers
Noradrenaline vs. terlipressin in the treatment of hepatorenal syndrome: A randomized study
|Journal of Hepatology|2012|269
Granulocyte Colony-Stimulating Factor in Severe Alcoholic Hepatitis: A Randomized Pilot Study
|The American Journal of Gastroenterology|2014|226
The Conundrum of ‘Long-COVID-19ʹ: A Narrative Review
|International Journal of General Medicine|2021|210
Effectiveness of an mHealth-Based Electronic Decision Support System for Integrated Management of Chronic Conditions in Primary Care
|Circulation|2019|126
Midodrine in patients with cirrhosis and refractory or recurrent ascites: A randomized pilot study
|Journal of Hepatology|2011|107